Disease Specific Interactions between Host Protein and DME (HOSPPI) |
Drug co-metabolism |
Cometabolized drug: Flunitrazepam |
Click to Show/Hide the Full List of HOSPPI: 6 HOSPPI
|
Cytochrome P450 1A2 (CYP1A2) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0003
DME Info
|
Uniprot ID |
|
Interaction Name |
CYP1A2-nfsB interaction |
[1], [2] |
Description |
The interaction, between human Cytochrome P450 1A2 and Oxygen-insensitive NADPH nitroreductase B from Escherichia coli which collectively metabolize the drug Flunitrazepam, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
Cytochrome P450 2A6 (CYP2A6) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0005
DME Info
|
Uniprot ID |
|
Interaction Name |
CYP2A6-nfsB interaction |
[1], [3] |
Description |
The interaction, between human Cytochrome P450 2A6 and Oxygen-insensitive NADPH nitroreductase B from Escherichia coli which collectively metabolize the drug Flunitrazepam, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
Cytochrome P450 2B6 (CYP2B6) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0020
DME Info
|
Uniprot ID |
|
Interaction Name |
CYP2B6-nfsB interaction |
[1], [3] |
Description |
The interaction, between human Cytochrome P450 2B6 and Oxygen-insensitive NADPH nitroreductase B from Escherichia coli which collectively metabolize the drug Flunitrazepam, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
Cytochrome P450 2C9 (CYP2C9) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0019
DME Info
|
Uniprot ID |
|
Interaction Name |
CYP2C9-nfsB interaction |
[1], [3] |
Description |
The interaction, between human Cytochrome P450 2C9 and Oxygen-insensitive NADPH nitroreductase B from Escherichia coli which collectively metabolize the drug Flunitrazepam, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
Cytochrome P450 3A4 (CYP3A4) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0001
DME Info
|
Uniprot ID |
|
Interaction Name |
CYP3A4-nfsB interaction |
[1], [8] |
Description |
The interaction, between human Cytochrome P450 3A4 and Oxygen-insensitive NADPH nitroreductase B from Escherichia coli which collectively metabolize the drug Flunitrazepam, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
Mephenytoin 4-hydroxylase (CYP2C19) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0021
DME Info
|
Uniprot ID |
|
Interaction Name |
CYP2C19-nfsB interaction |
[1], [10] |
Description |
The interaction, between human Mephenytoin 4-hydroxylase and Oxygen-insensitive NADPH nitroreductase B from Escherichia coli which collectively metabolize the drug Flunitrazepam, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
Cometabolized drug: Nitrofural |
Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI
|
Cytochrome P450 2D6 (CYP2D6) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0009
DME Info
|
Uniprot ID |
|
Interaction Name |
CYP2D6-nfsB interaction |
[4], [5] |
Description |
The interaction, between human Cytochrome P450 2D6 and Oxygen-insensitive NADPH nitroreductase B from Escherichia coli which collectively metabolize the drug Nitrofural, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
Cometabolized drug: Clonazepam |
Click to Show/Hide the Full List of HOSPPI: 2 HOSPPI
|
Cytochrome P450 3A4 (CYP3A4) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0001
DME Info
|
Uniprot ID |
|
Interaction Name |
CYP3A4-nfsB interaction |
[6], [7] |
Description |
The interaction, between human Cytochrome P450 3A4 and Oxygen-insensitive NADPH nitroreductase B from Escherichia coli which collectively metabolize the drug Clonazepam, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
RNA cytidine acetyltransferase (hALP) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0007
DME Info
|
Uniprot ID |
|
Interaction Name |
hALP-nfsB interaction |
[6], [14] |
Description |
The interaction, between human RNA cytidine acetyltransferase and Oxygen-insensitive NADPH nitroreductase B from Escherichia coli which collectively metabolize the drug Clonazepam, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
Cometabolized drug: Nitrazepam |
Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI
|
Cytochrome P450 3A4 (CYP3A4) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0001
DME Info
|
Uniprot ID |
|
Interaction Name |
CYP3A4-nfsB interaction |
[4], [9] |
Description |
The interaction, between human Cytochrome P450 3A4 and Oxygen-insensitive NADPH nitroreductase B from Escherichia coli which collectively metabolize the drug Nitrazepam, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
Cometabolized drug: Nitrobenzodiazepine |
Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI
|
NADPH-cytochrome P450 reductase (CPR) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0076
DME Info
|
Uniprot ID |
|
Interaction Name |
CPR-nfsB interaction |
[1], [11] |
Description |
The interaction, between human NADPH-cytochrome P450 reductase and Oxygen-insensitive NADPH nitroreductase B from Escherichia coli which collectively metabolize the drug Nitrobenzodiazepine, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
Cometabolized drug: CBL-954 |
Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI
|
Quinone reductase 1 (NQO1) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0097
DME Info
|
Uniprot ID |
|
Interaction Name |
NQO1-nfsB interaction |
[4], [12], [13] |
Description |
The interaction, between human Quinone reductase 1 and Oxygen-insensitive NADPH nitroreductase B from Escherichia coli which collectively metabolize the drug CBL-954, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
|
|
|
|
|
|